CPT 90664: Live Intranasal Pandemic Influenza Vaccine - OpenPayer

Summary & Overview

CPT 90664: Live Intranasal Pandemic Influenza Vaccine

CPT code 90664 denotes a live, intranasal influenza vaccine specifically formulated for pandemic use and administered via nasal spray. Nationally, pandemic influenza vaccines are a critical component of public health response and immunization programs; availability and appropriate coding ensure providers can document administration of a non-injectable, live attenuated formulation tailored for pandemic strains. Clear coding supports surveillance, reimbursement, and supply-chain tracking during outbreak responses.

Key payers referenced include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for this intranasal vaccine, guidance on typical sites of service where it is delivered, and what to expect in billing practice. The publication summarizes common modifiers associated with similar vaccine administrations and highlights areas where payers commonly provide coverage policies.

The content covers benchmarks and policy-relevant considerations such as coding accuracy for pandemic vaccine campaigns, distinctions between intranasal and injectable influenza products, and implications for outpatient and public health vaccination settings. Data not available in the input is noted where applicable. This briefing is aimed at billing staff, health system policy teams, and public health planners needing a focused, national-level reference on CPT code 90664.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare90664CPTinfluenza vaccineintranasal vaccinepandemic preparednessvaccine administrationimmunization codingoutpatient services

Billing Code Overview

CPT code 90664 represents a live, intranasal influenza (flu) vaccine formulated for pandemic use. This formulation is delivered as a nasal spray rather than by injection and is intended for active immunization against pandemic influenza strains.

Service Type: Live intranasal vaccine administration

Typical Site of Service: Outpatient clinic, public health clinic, community vaccination site, or other ambulatory care settings where intranasal immunizations are provided.

Clinical & Coding Specifications

Clinical Context

A typical patient scenario involves a school-aged child or otherwise healthy adult presenting to a primary care clinic, community health center, or public health vaccination site during a pandemic influenza season to receive a live attenuated intranasal influenza vaccine. The clinical workflow begins with registration and verification of patient identity and insurance (Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, Medicare). A brief medical screening reviews contraindications (e.g., pregnancy, immunocompromise, severe egg allergy, recent antiviral use) and documents current medications and chronic conditions. Informed consent for vaccination is obtained, vaccine lot number and expiration are recorded, and the intranasal administration is performed by a qualified clinician (pediatrician, family medicine physician, nurse practitioner, or registered nurse). Post-administration observation for adverse reactions (typically 15 minutes for those with history of allergies) follows. Documentation includes CPT 90664 (intranasal live pandemic influenza vaccine), vaccine manufacturer, lot, route, dose, site of administration (intranasal), and any applicable modifier (for example SL when state-supplied vaccine is used). Billing and claim submission include the appropriate payer and taxonomy for the administering clinician, with coding for the vaccine and any related visit services if medically necessary.

Coding Specifications

Modifier	Description	When to Use

CPT 90668: Influenza Vaccine, Split Virus for Pandemic Strain

cpt-90746-hepatitis-b-adult-immunization-im

CPT 90746: Hepatitis B Vaccine, Adult Dosage, Intramuscular

cpt-90756-quadrivalent-cell-derived-influenza-vaccine-0-5-ml-im-immunization

CPT 90756: Quadrivalent Cell-Derived Influenza Vaccine, 0.5 mL Intramuscular

cpt-90675-rabies-vaccine-intramuscular

CPT 90675: Rabies Vaccine, Intramuscular

cpt-90635-h5n1-cell-culture-adjuvanted-influenza-vaccine-injection

CPT 90635: H5N1 Cell-Culture Adjuvanted Influenza Vaccine

cpt-90673-recombinant-trivalent-influenza-vaccine-im-injection

CPT 90673: Recombinant Trivalent Influenza Vaccine, Intramuscular

cpt-90749-unlisted-vaccine-or-toxoid-procedure

CPT 90749: Unlisted Vaccine or Toxoid Procedure

cpt-90682-quadrivalent-recombinant-influenza-vaccine-im-im

CPT 90682: Quadrivalent Recombinant Influenza Vaccine, IM

cpt-90636-hepatitis-a-b-combined-vaccine-adult-immunization

CPT 90636: Adult Intramuscular Hepatitis A and B Combined Vaccine

cpt-90593-recombinant-chikungunya-vaccine-intramuscular

CPT 90593: Recombinant Chikungunya Vaccine, Intramuscular

Showing 1–10 of 101

00

Taxonomy Code	Specialty	Notes
207Q00000X	Family Medicine	Primary clinicians administering routine vaccinations and pandemic influenza immunizations.
207R00000X	Internal Medicine	Adult primary care providers who administer intranasal vaccines when indicated.
208000000X	Pediatrics	Pediatricians routinely administering influenza vaccines to children and adolescents.
363L00000X	Nurse Practitioner	Nurse practitioners who administer vaccines in clinic and public health settings.
163W00000X	Registered Nurse	RNs who administer vaccinations under standing orders and document immunizations.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`Z23`	Encounter for immunization	Primary diagnosis code used to indicate administration of a vaccine such as `CPT 90664`.
`J10.1`	Influenza due to other identified influenza virus with other respiratory manifestations	May justify vaccination in some contexts of exposure or to document treatment vs prevention workflows; not typically used for routine immunization encounters.
`Z00.129`	Encounter for routine child health examination without abnormal findings	Used when vaccine is administered during a routine well-child visit.
`Z02.89`	Encounter for other administrative examinations	Used when vaccination is given during school, travel, or occupational health visits where administrative exam codes apply.
`Z71.89`	Other specified counseling	Used when vaccination visit includes counseling beyond routine information, such as pandemic-specific risk counseling.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`90664`	Live attenuated influenza vaccine, for pandemic use, intranasal administration	Primary code for the intranasal pandemic influenza vaccine administered in this scenario.
`90460`	Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first vaccine/toxoid component	Billed when vaccine counseling and administration for pediatric patients requires separate reporting for the first component.
`90461`	Each additional vaccine/toxoid component administered, up to 8 component vaccines	Billed when multiple vaccine components are administered during the same visit.
`90471`	Immunization administration (intramuscular, subcutaneous, or intradermal), one vaccine (single or combination vaccine/toxoid)	Occasionally used for other influenza vaccine types (injectable) during the same season; not used for intranasal product but relevant when documenting alternative vaccine administration.
`99381`	Initial comprehensive preventive medicine evaluation and management of an individual, new patient; infant (younger than 1 year)	Example of a preventive visit during which influenza vaccination may be provided and documented; E/M codes like this may be billed separately when appropriate.

OpenPayer